{
    "2019-01-28": [
        [
            {
                "time": "2018-01-03",
                "original_text": "Dr. Reddy's (RDY) to Report Q3 Earnings: What's in Store?",
                "features": {
                    "keywords": [
                        "Dr. Reddy's",
                        "Q3 Earnings",
                        "Report"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-04",
                "original_text": "Allergan Hikes Quarterly Dividend by 2.8% Ahead of Q4 Results",
                "features": {
                    "keywords": [
                        "Allergan",
                        "Quarterly Dividend",
                        "Hikes",
                        "2.8%",
                        "Q4 Results"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-01-05",
                "original_text": "The Zacks Analyst Blog Highlights: J&J, Bristol-Myers, Lilly, AbbVie and Merck",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "J&J",
                        "Bristol-Myers",
                        "Lilly",
                        "AbbVie",
                        "Merck"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}